Evidence map›Paper›PMID 40662755›Full record

ArticleJournal of virology2025

Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses.

Michael A Carlock, Spencer R Pierce, Ted M Ross

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael A CarlockCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0003-4077-7386
Spencer R PierceCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Ted M RossCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0003-1947-7469

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Georgia Research Alliance GRA-001NIAID NIH HHS 75N93019C00052NIH HHS 75N93019C00052
6 · The paper itself

Abstract

Most people are exposed to influenza A and influenza B viruses (IBV) at an early age through natural infection or vaccination. These previous exposures can shape future immune responses and the ability to either recall memory B cells or generate IMPORTANCE: This report demonstrates how varying immunological backgrounds to influenza B virus influence vaccine-induced responses in mice. It further highlights that a broadly reactive influenza B virus hemagglutinin (HA) antigen stimulates higher levels of IgM-secreting cells compared to wild-type HA antigens.

Indexed as

Antibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza B virusInfluenza VaccinesAnimalsAntibodies, NeutralizingB-LymphocytesFemaleHumansImmunologic MemoryInfluenza, HumanMemory B CellsMiceMice, Inbred BALB COrthomyxoviridae InfectionsAntibodies, NeutralizingAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza Vaccinesbroadly-reactive antigensimmunological imprintinginfluenza B virusinfluenza vaccinesmemory B cells

Identifiers

PMID40662755
PMCPMC12363200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.